The promise of stem cell therapy for diabetes is exciting. The theoretical possibility of producing unlimited cells that could, once transplanted into a patient, respond immediately and physiologically to nutrients in a manner superior to any machine has driven intense research and development over the past 15 years. Recently, stem cell differentiation protocols have advanced to generate pancreatic islet beta-like cells that respond to glucose in vitro, although not yet in a manner similar to healthy beta cells. In this issue, James Johnson reviews progress in this field from the perspective of an islet biologist. Based on available evidence, he concludes that the field is yet to produce bona fide beta cells. The author urges researchers to raise the bar and employ more sensitive, robust and standardised assays to evaluate stem cell derived beta-like cells and to better understand the target of these cell engineering efforts, the healthy human beta cell.
Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation Thomas O. Mundinger, Gerald J. Taborsky Jr
In type 1 diabetes, impairment of the glucagon response to hypoglycaemia is coupled with normal responses to other stimuli, suggesting a defect that is restricted to mechanisms specifically activated by hypoglycaemia. Alongside loss of pancreatic islet beta cells, a defect in the autonomic pathway that stimulates the alpha cell contributes to impaired glucagon responses. In this issue, Mundinger and Taborsky review research showing an early and marked loss of islet sympathetic nerves in animal models of autoimmune diabetes, which results in impaired glucagon responses to sympathetic activation. Importantly, they also summarise very recent work demonstrating a similar nerve loss in humans with type 1 diabetes, contrasted with retention of these nerves in patients with type 2 diabetes. These data suggest that a sympathetic defect within the islet may contribute to the impairment of the glucagon response to hypoglycaemia that is seen early in human type 1 diabetes, but not in type 2 diabetes.
Competition for publication in Diabetologia continues to grow, and less than 20% of papers are accepted. Of all the high-quality papers that appear in this month's issue I want to draw your attention to five articles that I think are particularly interesting. The articles are summarised here. Our publisher, Springer, has kindly made the full text of each of these papers freely available. I hope you enjoy reading them! In recent decades, type 2 diabetes prevalence has increased considerably in Scotland. The extent to which this increase was related to increasing incidence or reduced mortality of patients was unknown. In this issue, Read et al report trends in type 2 diabetes incidence and mortality between 2004 and 2013 using data from the Scottish national diabetes register. The authors found that type 2 diabetes incidence remained stable during the study period, potentially reflecting a smaller pool of people with undiagnosed diabetes in the population or stable obesity prevalence rates in recent years. Trends in incidence rates varied by age and socioeconomic status, with incidence rates remaining stable or increasing in younger people, declining in older people and, after 2008, increasing in the most deprived groups. Over time, mortality rates declined but the excess risk of mortality in people with type 2 diabetes was 49% in women and 38% in men, compared with the non-diabetic population. It was concluded that the incidence of type 2 diabetes stabilised in recent years and, thus, declining mortality is likely to be responsible for the increase in prevalence. Nonetheless, prevention of type 2 diabetes remains important, specifically in socioeconomically deprived individuals.
Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets Hormonal crosstalk between the gut and pancreatic islets plays a major role in regulating postprandial insulin secretion, but the factors regulating islet secretion in the fasting state are less well established. In this issue Adriaenssens, Svendsen, Lam et al employ an RNA sequencing approach to quantify genes expressed in purified murine alpha, beta and delta cells, identifying pancreatic cell-specific G-protein coupled receptors and signalling pathways. Examination of the delta cell transcriptome revealed high cell-selective expression of the ghrelin receptor, suggesting a previously unrealised role of ghrelin in the control of somatostatin secretion. By single delta cell imaging and hormonal measurements in perfused pancreases, the authors demonstrate that ghrelin suppresses insulin secretion via paracrine inhibition of beta cells by somatostatin. The transcriptomic profiles provide a molecular basis for understanding how islets are regulated by local and circulating signals and highlight the importance of gut-islet and intra-islet crosstalk in the regulation of glucose homeostasis.
Placental endoplasmic reticulum stress in gestational diabetes: the potential for therapeutic intervention with chemical chaperones and antioxidants Hong-wa Yung, Patji Alnaes-Katjavivi, Carolyn J. P. Jones, Tatiana El-Bacha, Michaela Golic, Anne-Cathrine Staff, Graham J. Burton Gestational diabetes (GDM) is associated with an increased risk of complications of pregnancy, including pregnancyinduced hypertension, pre-eclampsia, stillbirth and fetal growth anomalies. Its incidence currently approaches 18% of all pregnancies. In this issue, Yung et al report evidence of endoplasmic reticulum (ER) stress in the trophoblast layer of the placenta. The trophoblast has a high metabolic rate because of its extensive endocrine activity and active transport functions, which are critical for normal fetal development. In response to this, the trophoblast produces lactate even under aerobic conditions. Culturing trophoblast cells in high glucose concentrations induced stress (similar to that observed in vivo), which was caused by acidification of the medium because of excessive lactate accumulation. The addition of vitamins C and E reduced acidification and prevented generation of ER stress, suggesting that these agents may have therapeutic benefits in GDM pregnancies, promoting placental health and, hence, fetal wellbeing. This article is the subject of a commentary in this issue by Alicia Jawerbaum.
